EVANGELISTI, CAMILLA
EVANGELISTI, CAMILLA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Ricercatori a tempo determinato
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES
2014-01-01 Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D; Evangelisti C; Martelli AM
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia.
2010-01-01 F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli.
Advances in Targeting Signal Transduction Pathways.
2012-01-01 J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko.
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting.
2016-01-01 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, LM; McCubrey, Ja; Martelli, AM.
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells.
2019-01-01 F. Charini, C. Evangelisti, G. Lattanzi, J.A. McCubrey, A.M. Martelli.
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy
2008-01-01 McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S.L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S.
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014-01-01 Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014-01-01 Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
2014-01-01 C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli.
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications.
2015-01-01 Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli.
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients?
2020-01-01 Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C.
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer.
2020-01-01 C. Evangelisti, F. Chiarini, F. Paganelli, S. Marmiroli, Alberto M. Martelli.
Cutting edge: the role of mTOR signaling in laminopathies.
2019-01-01 F. Chiarini, C. Evangelisti, V. Cenni, A. Fazio, F. Paganelli, A. M. Martelli, G. Lattanzi.
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
2014-01-01 F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli.
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
2012-01-01 Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM.
DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry.
2012-01-01 M. Okada; Y. Hozumi; T. Tanaka; Y. Suzuki; M. Yanagida; Y. Araki; C. Evangelisti; H. Yagisawa; M.K. Topham; A.M. Martelli; K. Goto
Elevated tgf b2 serum levels in emery-dreifuss muscular dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes
2018-01-01 Bernasconi P.; Carboni N.; Ricci G.; Siciliano G.; Politano L.; Maggi L.; Mongini T.; Vercelli L.; Rodolico C.; Biagini E.; Boriani G.; Ruggiero L.; Santoro L.; Schena E.; Prencipe S.; Evangelisti C.; Pegoraro E.; Morandi L.; Columbaro M.; Lanzuolo C.; Sabatelli P.; Cavalcante P.; Cappelletti C.; Bonne G.; Muchir A.; Lattanzi G.
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology.
2010-01-01 A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; J.A. McCubrey.
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.
2010-01-01 A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Cappellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey.
GSK-3: a multifaceted player in acute leukemias.
2021-01-01 A.M. Martelli, C. Evangelisti, F. Paganelli, F. Chiarini, J.A. McCubrey.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES |
Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D...; Evangelisti C; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. | F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. ...Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. | 2010-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in Targeting Signal Transduction Pathways. | J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. C...occo; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko. | 2012-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. | Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; ...Neri, LM; McCubrey, Ja; Martelli, AM. | 2016-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. | F. Charini, C. Evangelisti, G. Lattanzi, J.A. McCubrey, A.M. Martelli. | 2019-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy | McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S....L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. | 2008-01-01 | - | Elsevier Ltd. | 2.01 Capitolo / saggio in libro | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS |
Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin... D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS | Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. | C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. B...ertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli. | 2014-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. | Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli. | 2015-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? | Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-03498-v3(1).pdf |
| Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer. | C. Evangelisti, F. Chiarini, F. Paganelli, S. Marmiroli, Alberto M. Martelli. | 2020-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Cutting edge: the role of mTOR signaling in laminopathies. | F. Chiarini, C. Evangelisti, V. Cenni, A. Fazio, F. Paganelli, A. M. Martelli, G. Lattanzi. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | The Cutting Edge.pdf |
| Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling | F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evan...gelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli. | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. | Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari... PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry. | M. Okada; Y. Hozumi; T. Tanaka; Y. Suzuki; M. Yanagida; Y. Araki; C. Evangelisti; H. Yagisawa; M....K. Topham; A.M. Martelli; K. Goto | 2012-01-01 | CELLULAR SIGNALLING | - | 1.01 Articolo in rivista | - |
| Elevated tgf b2 serum levels in emery-dreifuss muscular dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes | Bernasconi P.; Carboni N.; Ricci G.; Siciliano G.; Politano L.; Maggi L.; Mongini T.; Vercelli L....; Rodolico C.; Biagini E.; Boriani G.; Ruggiero L.; Santoro L.; Schena E.; Prencipe S.; Evangelisti C.; Pegoraro E.; Morandi L.; Columbaro M.; Lanzuolo C.; Sabatelli P.; Cavalcante P.; Cappelletti C.; Bonne G.; Muchir A.; Lattanzi G. | 2018-01-01 | NUCLEUS | - | 1.01 Articolo in rivista | - |
| The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. | A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; J.A. McCubrey. | 2010-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-02-01576.pdf |
| Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. | A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Capp...ellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey. | 2010-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| GSK-3: a multifaceted player in acute leukemias. | A.M. Martelli, C. Evangelisti, F. Paganelli, F. Chiarini, J.A. McCubrey. | 2021-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |